The global 3D Bioprinting market size is estimated to be worth USD 1724 million by 2026, growing at a CAGR of 21.2% during the forecast period.
As a result of a present pandemic caused by the COVID-19 breakdown that has spread over the globe, healthcare systems in even affluent countries are overburdened and tired. There is a lack of materials for medical professionals, and the general public as the number of cases continues to climb. As a result, several 3D bioprinting market players produce significant quantities of 3D printers and related software. Because scientists (in patients) are exploiting new technology after preclinical trials are done for safety-testing, the COVID-19 pandemic has also assisted the creation of vaccines and drug testing. The medical industry is running out of ventilators and respirators as coronavirus cases continue to rise. Because of this 3D bioprinting technology, ventilators and respirators can now be manufactured to fill a gap in the market. This technology is being used to boost COVID-19 research by several biotherapeutic companies.
3D bioprinting technology in the healthcare industry has expanded in recent years. Bioprinting has developed as a realistic method for fabricating artificial tissues and organs, potentially transforming medical diagnosis and treatment. In addition, bioprinting companies worldwide are constantly innovating in regenerative medicine, tissue engineering, drug therapies, and stem cell therapy, attracting the attention of healthcare professionals and pharmaceutical companies who see a future with better patient care, individualized medical treatment, and an alternative to organ transplantation.
3D bioprinting has made significant progress in various medical applications, including skin tissue manufacture, cancer therapy, bone and cartilage formation, and liver modeling. In addition, advanced technologies provide a competitive edge to players, increasing their market share and position. For example, Poieskin, a 3D bioprinted skin model, was introduced by Poietis (France) in 2018. The human skin model is bioprinted utilizing primary human collagen and fibroblasts for the dermal layer and primary human keratinocytes for the epidermal layer.
As a result of expanded stem cell research efforts and financial help from the number of public-private partnerships, the stem cell and regenerative medicine businesses are expanding worldwide. In addition, the development of many stem cell product pipelines in emerging countries and applications of regenerative medicine in treating diseases are further contributing to the growing adoption of stem cell and regenerative medicine worldwide. In regenerative medicine, 3D bioprinting has a variety of applications. It’s employed in creating body parts including cartilage, the heart, and the liver, among other organs, as well as in the treatment of various diseases. Similarly, stem cells are widely employed for bioprinting various bones and tissues on a big scale. These cells quickly react to growth stimulants and form the necessary 3D structures.
3D bioprinting is a new field in the healthcare industry that is seeing rapid technological improvements, driving up the need for trained personnel who can run these systems successfully. Continuous process monitoring is required for optimal usage of 3D bioprinting technology. Due to uncontrollable process variables (such as batch and machine differences) and material differences, the consistency of the process differs across platforms. These technologies and processes necessitate the expertise of a trained individual who can comprehend and effectively operate a 3D bioprinter.
The ability to design spatial objects is the most significant component of the 3D printing service. However, designing a 3D-printed object is more complicated than creating it. Similarly, 3D printed models contain complicated geometrical features that necessitate technical help when printing with a material that shrinks a lot. To avoid errors and printing failure, qualified personnel must carry out these procedures. The utilization of different technologies is also the main problem facing the 3D bioprinting sector. As a result, there is a greater need for highly skilled employees to handle operations and debug 3D bioprinting techniques.
Living cells are employed in 3D bioprinting to create items for various medicinal uses. For example, it’s widely engaged in developing tissues and organs to meet the world’s growing need for organ transplantation. The use of bio-printed objects inside the human body, on the other hand, raises biosafety problems and may even violate religious convictions. Furthermore, the supply of biomaterials utilized in the development of 3D bio-printed objects and worries about waste disposal are two main problems preventing persons from adopting 3D bioprinting.
Avail sample market brochure of the report to evaluate report usefulness, get a copy @ https://www.marketdataforecast.com/market-reports/three-d-bioprinting-market/request-sample
KEY MARKET INSIGHTS:
- The market is divided into hydrogels, extracellular matrices, living cells, and other biomaterials based on the material. Due to increased R&D in this category and increased governmental and private investments to support research.
- The skin, bone and cartilage, and blood arteries are sub-segmented in clinical applications based on the application. However, due to technological advances and new product launches in this area, the clinical applications segment will likely dominate the market.
- Based on technology, the market is divided into magnetic 3d bioprinting, laser-assisted bioprinting, inkjet 3d bioprinting, and micro extrusion bioprinting. A section of the whole Inkjet market dominates the primary market because it allows biomaterials to print complicated living organs or tissues on culture substrates. As a result, the widespread use of inkjet-based printing in the medical profession contributes to the segment’s growth.
- Due to a substantial present customer base that will drive demand for 3D bioprinting, a vast scope of 3D printing in medical services, rising R&D for 3D printing, and government backing and tax incentives, Asia-Pacific is the fastest-growing market for 3D bioprinting.
- Chinese researchers have made significant advances in 3D bioprinting technologies, such as the Liquid-in-Liquid printing method. When liquid polymers come together in this way, they form a stable membrane. According to the researchers, the resulting liquid structures can hold their shape for up to 10 days before merging. Using this new technology, they could print a variety of complex shapes. This has also paved the way for sophisticated 3D-printed tissues, including living cells, to be created.
- According to the Japanese government, the regenerative medicine industry is expected to reach JPY 1 trillion by 2030. The New Energy and Industrial Technology Development Organization (NEDO) believes that emerging and innovative technologies, such as 3D bioprinting will likely lead the market in the near future.
- The Government of India (GoI) and the United States agreed to work on 3D bioprinting regenerative medicine research and development in July 2019. This collaboration entails the exchange of teachers and students for the sharing of scientific ideas, information, and technologies and the combined use of scientific infrastructure for research, particularly in the field of 3D bioprinting.
- South Korea’s government has announced intentions to invest around USD 37 million in the country’s 3D printing development. Furthermore, to increase its competitiveness and ability to meet demand, the country’s Ministry of Science announced intentions to invest a significant percentage of its budget on various 3D applications.
- Organovo Holdings, Inc., CELLINK, Allevi Inc., Aspect Biosystems Ltd., EnvisionTEC GmbH, Poietis, TeVido BioDevices, Nano3D Biosciences, Inc., ROKIT Healthcare, Digilab, Inc., regenHU, GeSiM, Advanced Solutions Life Sciences, and Regenovo Biotechnology Co., Ltd. are a few of the noteworthy companies operating in the global 3d bioprinting market.
The report can be customized as per the requirements; talk to our team @ https://www.marketdataforecast.com/market-reports/three-d-bioprinting-market/customization
SEGMENTS ANALYZED IN THIS REPORT:
By Component:
- 3D Bioprinters
- Microextrusion bioprinting
- Inkjet 3D Bioprinting
- Laser-assisted Bioprinting
- Magnetic 3D Bioprinting
- Other technologies
- Bio inks
- Natural Bio inks
- Hybrid Bio inks
- Synthetic Bio inks
By Application:
- Research Applications
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
- Clinical Application
- Skin
- Bone & Cartilage
- Blood Vessels
- Other Clinical Applications
By Material:
- Living Cells
- Hydrogels
- Extracellular Matrices
- Other Biomaterials
By End User:
- Research Organization & Academic Institutes
- Biopharmaceuticals Companies
- Hospitals
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Browse Regional Reports:
Latin America 3D bioprinting Market
About MarketDataForecast:
Market Data Forecast is a firm working in market research, business intelligence, and consulting. We have rich research and consulting experience for various business domains to cater to individual and corporate clients’ needs.
Contact Us:
Market Data Forecast
Phone: +1-888-702-9626
Email: contact@marketdataforecast.com